Site icon News Digging

WSJ News Exclusive | Pfizer in Talks to Acquire Seagen in Deal Likely Valued at More Than $30 Billion

wsj.com
WSJ News Exclusive | Pfizer in Talks to Acquire Seagen in Deal Likely Valued at More Than Billion

WSJ News Exclusive | Pfizer in Talks to Acquire Seagen in Deal Likely Valued at More Than $30 Billion

The potential deal, likely valued at more than $30 billion, would help Pfizer add to its lineup of cancer treatments.

Exit mobile version